New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors

New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors

Seven of the most frequent spinocerebellar ataxias (SCAs) are caused by a pathological expansion of a cytosine, adenine and guanine (CAG) trinucleotide repeat located in exonic regions of unrelated genes, which in turn leads to the synthesis of polyglutamine (polyQ) proteins. PolyQ proteins are pron...

Full description

Bibliographic Details
Main Authors:	Fabiola V. Borbolla-Jiménez, María Luisa Del Prado-Audelo, Bulmaro Cisneros, Isaac H. Caballero-Florán, Gerardo Leyva-Gómez, Jonathan J. Magaña
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Pharmaceutics
Subjects:	spinocerebellar ataxias polyglutamine gene therapy expanded triplet repeat antisense and interferent technology DNA editing systems
Online Access:	https://www.mdpi.com/1999-4923/13/7/1018

Similar Items

Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature
by: Evelyn Lindsay, et al.
Published: (2017-07-01)

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
by: Ricardo Afonso-Reis, et al.
Published: (2021-04-01)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
by: Anna Niewiadomska-Cimicka, et al.
Published: (2020-06-01)

Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review
by: Jun Young Park, et al.
Published: (2020-08-01)

Polyglutamine toxicity induces rod photoreceptor division, morphological transformation or death in Spinocerebellar ataxia 7 mouse retina
by: Marina G. Yefimova, et al.
Published: (2010-10-01)

Population genetics of spinoсerebellar ataxias caused by polyglutamine expansions
by: A. N. Shuvaev, et al.
Published: (2019-07-01)

Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
by: Rafael Nambo-Venegas, et al.
Published: (2020-03-01)

Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
by: Melvin M. Evers, et al.
Published: (2013-10-01)

Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
by: Craig S. McIntosh, et al.
Published: (2021-10-01)

Clinical and genetic profile in index patients with spinocerebellar ataxia type 3 in Indonesia: case report
by: Siti Aminah, et al.
Published: (2021-07-01)

Spinocerebellar ataxia type 40: A case report and literature review
by: Han Fengyue, et al.
Published: (2021-10-01)

Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6
by: Wei-Ling Tsou, et al.
Published: (2016-12-01)

Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture
by: Kristen H. Schuster, et al.
Published: (2022-08-01)

Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
by: Matthew V. Prifti, et al.
Published: (2023-01-01)

Autophagy is dysregulated in spinocerebellar ataxia type 2
by: Adriana Marcelo, et al.
Published: (2022-12-01)

Spinocerebellar ataxia 12 patients have better quality of life than spinocerebellar ataxia 1 and 2
by: Surekha Dabla, et al.
Published: (2022-01-01)

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
by: Luis C. Velázquez-Pérez, et al.
Published: (2017-09-01)

Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
by: An-Hsun Chou, et al.
Published: (2006-02-01)

Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
by: Inês T. Afonso, et al.
Published: (2022-10-01)

A Novel Calpain Inhibitor Compound Has Protective Effects on a Zebrafish Model of Spinocerebellar Ataxia Type 3
by: Katherine J. Robinson, et al.
Published: (2021-09-01)

Genetic Modeling of the Neurodegenerative Disease Spinocerebellar Ataxia Type 1 in Zebrafish
by: Mohamed A. Elsaey, et al.
Published: (2021-07-01)

A pedigree of spinocerebellar ataxia type 2
by: Yan-xin LI, et al.
Published: (2019-03-01)

Development of a Polymeric Pharmacological Nanocarrier System as a Potential Therapy for Spinocerebellar Ataxia Type 7
by: Fabiola V. Borbolla-Jiménez, et al.
Published: (2023-11-01)

Research progress of spinocerebellar ataxia type 1
by: Lin-wei ZHANG, et al.
Published: (2014-05-01)

Occupational therapy in spinocerebellar ataxia type 3: an open-label trial
by: R.C.R. Silva, et al.
Published: (2010-06-01)

Spinocerebellar Ataxia 27: A Review and Characterization of an Evolving Phenotype
by: Christopher L. Groth, et al.
Published: (2018-01-01)

Clinical and neuroimaging study of spinocerebellar ataxia type 2
by: Yuan-yuan CHEN, et al.
Published: (2013-06-01)

Professor Wadia’s contributions to neurology and spinocerebellar ataxia type 2
by: Fernando Spina Tensini, et al.

Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila
by: Qian Zhang, et al.
Published: (2016-03-01)

Cell-based therapeutic strategies for treatment of spinocerebellar ataxias: an update
by: Joana Sofia Correia, et al.
Published: (2023-01-01)

A clinical report of the massive CAG repeat expansion in spinocerebellar ataxia type 2: Severe onset in a Mexican child and review previous cases
by: José Sánchez-Corona, et al.
Published: (2020-08-01)

Dataset on the effect of Rubicon overexpression on polyglutamine-induced locomotor dysfunction in Drosophila
by: Masaki Oba, et al.
Published: (2021-08-01)

Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation
by: Nester Mitchell, et al.
Published: (2019-09-01)

Understanding the Pathophysiology of Spinocerebellar Ataxias through genetics, neurophysiology, structural and functional neuroimaging
by: Pramod Kumar Pal
Published: (2015-12-01)

Zebrafish Models of Autosomal Dominant Ataxias
by: Ana Quelle-Regaldie, et al.
Published: (2021-02-01)

A case of Spinocerebellar Ataxia from ethnic tribe of Assam
by: Kayal Ashok, et al.
Published: (2011-01-01)

Genetic Distribution of Five Spinocerebellar Ataxia Microsatellite Loci in Mexican Native American Populations and Its Impact on Contemporary Mestizo Populations
by: Rocío Gómez, et al.
Published: (2022-01-01)

Dystonia and dysphagia in spinocerebellar ataxia 1 portends a severe phenotype
by: Sahil Mehta, et al.
Published: (2020-01-01)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
by: Adriano M. de Assis, et al.
Published: (2017-09-01)

Splice isoform-specific suppression of the CaV2.1 variant underlying spinocerebellar ataxia type 6
by: Wei-Ling Tsou, et al.
Published: (2011-09-01)